Headaches are one of the most common medical complaints, but some headache conditions are more serious than others. Idiopathic intracranial hypertension (IIH) is a condition caused by increased pressure around the brain, which can lead to vision problems and chronic pain.
Emerging research suggests that semaglutide may help manage IIH symptoms, especially in patients with obesity-related risk factors.
This blog will examine the relationship between semaglutide and IIH and how it can help treat this condition.
What Is Idiopathic Intracranial Hypertension (IIH)?
Idiopathic intracranial hypertension (IIH) is a neurological condition characterized by increased pressure inside the skull. This pressure occurs when cerebrospinal fluid (CSF) accumulates and puts pressure on the brain and optic nerve.
The term “idiopathic” means the exact cause is unknown, while “intracranial hypertension” refers to high pressure inside the skull.
IIH was previously called pseudotumor cerebri because its symptoms can resemble those of a brain tumor, even though no tumor is present.
IIH mainly affects people with obesity, particularly young women of childbearing age. While it can occur in individuals of any weight or age, the incidence is significantly higher in those who are overweight or obese.
If untreated, IIH can lead to complications such as vision damage due to prolonged pressure on the optic nerve. Early diagnosis and treatment are important for preserving vision and improving quality of life.
Symptoms and Signs of IIH
The most common signs and symptoms of idiopathic intracranial hypertension are severe and persistent headaches with a throbbing or pulsating quality. Headaches may worsen with changes in body position, such as when standing up or lying down. The pain is typically located behind the eyes or in the back of the head.
People with IIH may also experience blurry vision or difficulty focusing. You may also see double or experience vision loss.
Other IIH symptoms can also include:
- Tinnitus (ringing in the ears)
- Nausea and vomiting
- Papilledema
- Dizziness
- Shoulder and neck pain
- Photophobia
Who Might Get Idiopathic Intracranial Hypertension?
Women are more likely to have IIH than men. Women make up about 19 out of every 20 cases of idiopathic intracranial hypertension. Most are between the ages of 20 and 50.
You may also develop IIH if you have:
- Obesity. Obesity is strongly associated with an increased risk of developing IIH. The condition predominantly affects people with obesity, particularly women of childbearing age. However, IIH can also occur in people of normal weight or men.
- Hormonal disorders. Conditions such as polycystic ovary syndrome (PCOS) or hormonal therapies, including oral contraceptives and hormone replacement therapy, may increase the risk.
- Medications. Some medications, such as certain antibiotics, corticosteroids, and retinoids, have been linked to the development of IIH.
- Metabolic disorders. Conditions like metabolic syndrome or insulin resistance may contribute to the development of IIH.
What Is the Connection Between IIH and Obesity?
While the connection between obesity and other health issues—like type 2 diabetes, cancer, heart difficulties, and sleep apnea—is commonly known, people with obesity are also at risk for developing several other dangerous conditions that are not as well recognized. IIH is one of those.
Obesity is believed to contribute to the development of IIH through several mechanisms. Excess fatty tissue, particularly in the abdomen, can increase intra-abdominal pressure, increasing intracranial pressure by transmitting pressure via the cerebrospinal fluid.
Hormonal imbalances associated with obesity, such as insulin resistance and hyperinsulinemia, may also contribute to increased cerebrospinal fluid production and intracranial pressure.
Weight loss, either through lifestyle modifications, medication, or bariatric surgery, has been shown to improve IIH symptoms and reduce intracranial pressure in obese people with IIH.
Does Semaglutide Treat IIH?
Studies suggest that semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, may be an effective treatment option for idiopathic intracranial hypertension (IIH), especially in people with obesity.
In a pilot study involving people with IIH and a body mass index (BMI) of 30 or higher, participants who received GLP-1 agonists alongside usual-care weight management experienced significant weight loss compared to those undergoing usual-care weight management alone.
GLP-1 agonist treatment was also associated with favorable outcomes in headache reduction, as evidenced by a higher proportion of participants achieving a 50% reduction in headache frequency.
GLP-1, a hormone that affects blood glucose regulation and appetite suppression, is involved in IIH treatment. GLP-1 acts via various pathways, including stimulating insulin release, inhibiting glucagon secretion, and reducing appetite through receptors in brain regions regulating food intake.
GLP-1 receptors are also expressed in the choroid plexus epithelial cells, where GLP-1 binding reduces cerebrospinal fluid secretion, ultimately lowering intracranial pressure.
This suggests a potential therapeutic role for GLP-1 agonists in IIH management, targeting both weight loss and intracranial pressure reduction.
How NP2GO Can Help
At NP2GO, we understand people’s challenges in achieving and maintaining weight loss, especially in conditions like IIH, where obesity is a significant risk factor. We are dedicated to providing comprehensive and effective solutions to support our clients on their weight loss journey.
Our weight management programs may include medications such as semaglutide (Ozempic and Wegovy) when clinically appropriate. These medications can help support weight loss and may improve symptoms associated with obesity-related IIH.
Our healthcare providers monitor treatment progress through regular follow-up visits to ensure safety and effectiveness. We also provide guidance on nutrition, exercise, stress management, and lifestyle modifications to support long-term health.
If you’re overweight or obese and are experiencing health issues associated with your weight, or you wish to take action to reduce the risk of experiencing those problems in the future, please book a consultation with us today or call us at 405-696-7003 to discuss how you can start your weight loss journey.